NO902634D0 - Fremgangsmaate ved fremstilling av stabil frysetoerket polyhematoporfyrineter/ester-blanding. - Google Patents

Fremgangsmaate ved fremstilling av stabil frysetoerket polyhematoporfyrineter/ester-blanding.

Info

Publication number
NO902634D0
NO902634D0 NO902634A NO902634A NO902634D0 NO 902634 D0 NO902634 D0 NO 902634D0 NO 902634 A NO902634 A NO 902634A NO 902634 A NO902634 A NO 902634A NO 902634 D0 NO902634 D0 NO 902634D0
Authority
NO
Norway
Prior art keywords
freeze dried
polyhematoporphyrineter
procedure
ester mixture
stable freeze
Prior art date
Application number
NO902634A
Other languages
English (en)
Other versions
NO902634L (no
NO176645B (no
NO176645C (no
Inventor
Bruce E Haeger
James R Lawter
Vijay H Naringrekar
Michael C Cucolo
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of NO902634D0 publication Critical patent/NO902634D0/no
Publication of NO902634L publication Critical patent/NO902634L/no
Publication of NO176645B publication Critical patent/NO176645B/no
Publication of NO176645C publication Critical patent/NO176645C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO902634A 1989-06-14 1990-06-13 Fremgangsmåte ved fremstilling av stabil frysetörket polyhematoporfyrineter/ester-blanding NO176645C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/366,374 US5059619A (en) 1989-06-14 1989-06-14 Stable freeze-dried polyhematoporphyrin ether/ester

Publications (4)

Publication Number Publication Date
NO902634D0 true NO902634D0 (no) 1990-06-13
NO902634L NO902634L (no) 1990-12-17
NO176645B NO176645B (no) 1995-01-30
NO176645C NO176645C (no) 1995-05-10

Family

ID=23442747

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902634A NO176645C (no) 1989-06-14 1990-06-13 Fremgangsmåte ved fremstilling av stabil frysetörket polyhematoporfyrineter/ester-blanding

Country Status (26)

Country Link
US (1) US5059619A (no)
EP (1) EP0402637B1 (no)
JP (1) JP3112918B2 (no)
KR (1) KR0164845B1 (no)
CN (1) CN1058388C (no)
AR (1) AR244549A1 (no)
AT (1) ATE144703T1 (no)
AU (1) AU625549B2 (no)
CA (1) CA2018751C (no)
CZ (1) CZ283309B6 (no)
DD (1) DD295087A5 (no)
DE (1) DE69029012T2 (no)
DK (1) DK0402637T3 (no)
ES (1) ES2095846T3 (no)
FI (1) FI101597B (no)
GR (1) GR3021511T3 (no)
HU (1) HU215522B (no)
IE (1) IE902137A1 (no)
IL (1) IL94448A (no)
NO (1) NO176645C (no)
NZ (1) NZ233953A (no)
PL (1) PL164744B1 (no)
PT (1) PT94344B (no)
RU (1) RU2019990C1 (no)
TW (1) TW225475B (no)
ZA (1) ZA904599B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
KR100980153B1 (ko) 2000-11-29 2010-09-03 피씨아이 바이오테크 에이에스 사이토졸 내로의 분자 전달을 위한 광화학적 내부이행
KR101180548B1 (ko) 2000-11-29 2012-09-06 피씨아이 바이오테크 에이에스 사이토졸 내로의 바이러스 매개된 분자 전달을 위한 광화학적 내부이행
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
CN103961323B (zh) * 2013-02-05 2017-10-17 浙江海正药业股份有限公司 一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2858320A (en) * 1956-04-02 1958-10-28 Baxter Laboratories Inc Stable hematoporphyrin
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
ATE91625T1 (de) * 1985-04-30 1993-08-15 Nippon Petrochemicals Co Ltd Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy

Also Published As

Publication number Publication date
PT94344A (pt) 1991-02-08
AR244549A1 (es) 1993-11-30
HUT54888A (en) 1991-04-29
FI101597B1 (fi) 1998-07-31
AU5708990A (en) 1990-12-20
NO902634L (no) 1990-12-17
HU215522B (hu) 1999-01-28
KR0164845B1 (ko) 1999-01-15
AU625549B2 (en) 1992-07-16
CN1047973A (zh) 1990-12-26
DE69029012T2 (de) 1997-02-27
IE902137A1 (en) 1991-01-02
IE902137L (en) 1990-12-14
CA2018751C (en) 2001-08-21
JP3112918B2 (ja) 2000-11-27
CZ283309B6 (cs) 1998-02-18
KR910000146A (ko) 1991-01-29
CA2018751A1 (en) 1990-12-14
PL164744B1 (pl) 1994-10-31
NO176645B (no) 1995-01-30
RU2019990C1 (ru) 1994-09-30
ATE144703T1 (de) 1996-11-15
TW225475B (no) 1994-06-21
EP0402637A3 (en) 1991-04-03
DE69029012D1 (de) 1996-12-05
ZA904599B (en) 1991-04-24
DK0402637T3 (da) 1997-04-07
IL94448A (en) 1994-06-24
ES2095846T3 (es) 1997-03-01
FI101597B (fi) 1998-07-31
CN1058388C (zh) 2000-11-15
JPH0331283A (ja) 1991-02-12
DD295087A5 (de) 1991-10-24
GR3021511T3 (en) 1997-01-31
FI902966A0 (fi) 1990-06-13
NZ233953A (en) 1992-08-26
PT94344B (pt) 1997-04-30
CS9002889A2 (en) 1991-11-12
IL94448A0 (en) 1991-03-10
HU903850D0 (en) 1990-11-28
EP0402637A2 (en) 1990-12-19
US5059619A (en) 1991-10-22
EP0402637B1 (en) 1996-10-30
NO176645C (no) 1995-05-10

Similar Documents

Publication Publication Date Title
FI922151A (fi) Metall-peptidkompositioner och metoder foer stimulering av haortillvaext.
NO902634D0 (no) Fremgangsmaate ved fremstilling av stabil frysetoerket polyhematoporfyrineter/ester-blanding.
GB9027055D0 (en) Organic compounds
AU1736088A (en) Methods of treating tumors with compositions of catecholic butanes
AU3572989A (en) Process for low-emission drying of wood chips
AU1520188A (en) Compositions and methods of treatment of timber
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
NZ217959A (en) Imidazoquinazoline derivatives and pharmaceutical compositions
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
DK139590D0 (da) Indretning ved forbraending af braendestykker af trae
NO914997L (no) Fremgangsmaate ved behandling av sandstensformasjoner
HUT46839A (en) Herbicide compositions containing phenoxy-phenyl-thiourea-, isothiourea- and carbodiimide derivatives as active components and process for producing the active components
FI810380L (fi) Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
ZA881170B (en) Compositions and methods for treating wood
PT90039A (pt) Processo de preparacao de oxidos de 1,2,4-benzotriazina e de composicoes faemaceuticas que os contem
ATE135232T1 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
DK228289A (da) Anvendelse af gonadoliberinderivater ved fremstilling af laegemidler til behandling af svulster
NZ336499A (en) Isoindoline boron compounds and their use in preparing quinolonecarboxylic acids
GR920100421A (el) Τετραυδροβενζοθειενοπυριδινες εχουσα δραση κ.ν.ς.
NO833270L (no) Fremgangsmaate ved behandling av virke
IL81837A0 (en) Methods and compositions for stabilization and preservation of biological materials in dried state,their use in solid phase immuno-assays
DE69002027D1 (de) (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid.
NO932700D0 (no) Fremgangsmaate ved fremstilling av etoksyetansulfonater

Legal Events

Date Code Title Description
MK1K Patent expired